Certified by Founder Lodge
Poplar Therapeutics
United States - Boston, MA
START UP
1 Disclosed Funding Rounds $50,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Poplar Therapeutics is a clinical-stage immunology company developing a new class of anti-IgE therapy to challenge convention in allergic disease treatment. Its lead program, PHB-050, is a ne
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 09 ,2026 | Series A | $50,000,000 | |
| March, 06 ,2026 | Series A | $45,000,000.00 |
Vida Ventures, LLC
SR One Capital Management
Platanus
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Zócalo Health | $15,000,000 | (Apr 24, 2026)
BAND | $17,000,000 | (Apr 24, 2026)
Rilian | $17,500,000 | (Apr 24, 2026)
Brev.io | $3,300,000 | (Apr 24, 2026)
Omni | $120,000,000 | (Apr 24, 2026)
